Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions
Acta Radiologica · 2025
DOI: 10.1177/02841851251323965 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Acta Radiologica, 2025. Verfasst von Akahiko Sato und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Gadolinium DTPA, Contrast Media. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
It can be difficult to differentiate hypervascular hepatocellular carcinoma (HCC) from hypervascular pseudolesion (HPL) such as arteriovenous shunts.
Purpose
To determine retrospectively whether double-layer detector computed tomography (DLCT) can differentiate HCC from HPL compared to gadoxetate-enhanced magnetic resonance imaging (EOB-MRI). Material and Methods We retrospectively analyzed 46 patients who underwent EOB-MRI and DLCT for suspected HCCs. Arterial/portal phase and hepatobiliary phase (HBP) on EOB-MRI, T2-weighted (T2W) imaging, diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC), CT value, iodine-density (ID), atomic-number (Zeff), and electron-density (ED) of the lesion and liver were evaluated. The reduction rates of ID (R-ID) between each phase of the arterial/portal phase on EOB-MRI were calculated. ROC analysis was performed to determine the accuracy for differentiating HCC from HPL.
Results
There were 55 HCCs and 14 HPLs. On DWI, 42, 11, and two HCCs showed high, slightly high, and iso intensity, respectively. However, all 14 HPLs showed iso intensity on DWI. Area under ROC curve (AUC) of DWI (0.982, 95% confidence interval [CI]=0.957–1) was significantly higher than that of HBP (AUC=0.714; 95% CI=0.580–0.849; P < 0.001), R-ID (AUC=0.742, 95% CI=0.580–0.903; P = 0.004), and ED of portal phase (AUC=0.786, 95% CI=0.640–0.891; P = 0.001) in differentiating HCC and HPL. ADC (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
ORCID-Profile: Masahiro Okada
Zitieren
APA
Sato, A., Okada, M., Tago, K., Nakazawa, Y., Mizuno, M., Miyauchi, T., & Kobashi, Y. (2025). Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions. Acta Radiologica. https://doi.org/10.1177/02841851251323965
Vancouver
Sato A, Okada M, Tago K, Nakazawa Y, Mizuno M, Miyauchi T, et al. Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions. Acta Radiologica. 2025. doi:10.1177/02841851251323965
BibTeX
@article{Sato2025,
author = {Sato, Akahiko and Okada, Masahiro and Tago, Kenichiro and Nakazawa, Yujiro and Mizuno, Mariko and Miyauchi, Takahiro and Kobashi, Yuko},
title = {Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions},
journal = {Acta Radiologica},
year = {2025},
doi = {10.1177/02841851251323965}
}
EUVIMED